ID

19693

Descrição

A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00356681

Link

https://clinicaltrials.gov/show/NCT00356681

Palavras-chave

Versões (1)
  1. 22/01/2017 22/01/2017 -
Transferido a

22 de janeiro de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY 4.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Breast Neoplasms NCT00356681

Inglês

Eligibility Breast Neoplasms NCT00356681

1 Formulários  
Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically or cytologically confirmed adenocarcinoma of the breast with locally recurrent or metastatic disease.
Descrição

Breast adenocarcinoma | Recurrent disease Local | Neoplasm Metastasis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0858252
UMLS CUI [2,1]
C0277556
UMLS CUI [2,2]
C0205276
UMLS CUI [3]
C0027627
measurable disease by recist guidelines.
Descrição

Measurable Disease

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1513041
tumor (primary or metastatic) must be her2 negative.
Descrição

Human epidermal growth factor 2 negative carcinoma of breast Primary | Human epidermal growth factor 2 negative carcinoma of breast metastatic

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2316304
UMLS CUI [1,2]
C0205225
UMLS CUI [2,1]
C2316304
UMLS CUI [2,2]
C1522484
adequate organ and hematologic function. exclusion:
Descrição

organ function | Hematologic function | Exclusion

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0678852
UMLS CUI [2]
C0221130
UMLS CUI [3]
C2828389
taxane treatment within 12 months prior to registration.
Descrição

taxane

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0215136
prior chemotherapy for locally recurrent or metastatic breast cancer (prior endocrine therapy is permitted).
Descrição

Chemotherapy Breast cancer recurrent Local | Chemotherapy Secondary malignant neoplasm of female breast | Hormone Therapy

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C0278493
UMLS CUI [1,3]
C0205276
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0346993
UMLS CUI [3]
C0279025
prior radiation therapy, radiofrequency ablation, percutaneous cryotherapy or hepatic chemoembolization on all sites of measurable disease.
Descrição

Therapeutic radiology procedure | Radiofrequency ablation | Cryosurgery Percutaneous | Chemoembolization of hepatic artery Measurable Disease Site All

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1522449
UMLS CUI [2]
C0850292
UMLS CUI [3,1]
C0010408
UMLS CUI [3,2]
C0522523
UMLS CUI [4,1]
C2711393
UMLS CUI [4,2]
C1513041
UMLS CUI [4,3]
C1515974
UMLS CUI [4,4]
C0444868
current or prior history of central nervous system metastases.
Descrição

CNS metastases

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0686377
peripheral neuropathy ≥ grade 2 (ctcae v3.0) at registration.
Descrição

Peripheral Neuropathy CTCAE Grades

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
history of arterial or venous thrombosis within 1 year prior to registration.
Descrição

Arterial thrombosis | Venous Thrombosis

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0151942
UMLS CUI [2]
C0042487
history of bleeding diathesis or bleeding within 14 days of registration.
Descrição

Bleeding tendency | Hemorrhage

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1458140
UMLS CUI [2]
C0019080
uncontrolled hypertension (systolic >145 mmhg; diastolic >85 mmhg).
Descrição

Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure

Tipo de dados

boolean

Alias
UMLS CUI [1]
C1868885
UMLS CUI [2]
C0871470
UMLS CUI [3]
C0428883
clinically significant cardiac disease within 12 months of registration.
Descrição

Heart Disease Clinical Significance

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C2826293
known hiv positive, hepatitis c positive or hepatitis b surface antigen positive.
Descrição

HIV Seropositivity | Hepatitis C positive | Hepatitis B surface antigen positive

Tipo de dados

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C1112419
UMLS CUI [3]
C0149709
prior treatment with vegfr targeted therapies.
Descrição

Targeted Therapy VEGFR

Tipo de dados

boolean

Alias
UMLS CUI [1,1]
C2985566
UMLS CUI [1,2]
C0148199
Voltar ao início da página

Similar models

Eligibility Breast Neoplasms NCT00356681

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
Breast adenocarcinoma | Recurrent disease Local | Neoplasm Metastasis
Item
histologically or cytologically confirmed adenocarcinoma of the breast with locally recurrent or metastatic disease.
boolean
C0858252 (UMLS CUI [1])
C0277556 (UMLS CUI [2,1])
C0205276 (UMLS CUI [2,2])
C0027627 (UMLS CUI [3])
Measurable Disease
Item
measurable disease by recist guidelines.
boolean
C1513041 (UMLS CUI [1])
Human epidermal growth factor 2 negative carcinoma of breast Primary | Human epidermal growth factor 2 negative carcinoma of breast metastatic
Item
tumor (primary or metastatic) must be her2 negative.
boolean
C2316304 (UMLS CUI [1,1])
C0205225 (UMLS CUI [1,2])
C2316304 (UMLS CUI [2,1])
C1522484 (UMLS CUI [2,2])
organ function | Hematologic function | Exclusion
Item
adequate organ and hematologic function. exclusion:
boolean
C0678852 (UMLS CUI [1])
C0221130 (UMLS CUI [2])
C2828389 (UMLS CUI [3])
taxane
Item
taxane treatment within 12 months prior to registration.
boolean
C0215136 (UMLS CUI [1])
Chemotherapy Breast cancer recurrent Local | Chemotherapy Secondary malignant neoplasm of female breast | Hormone Therapy
Item
prior chemotherapy for locally recurrent or metastatic breast cancer (prior endocrine therapy is permitted).
boolean
C0392920 (UMLS CUI [1,1])
C0278493 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C0346993 (UMLS CUI [2,2])
C0279025 (UMLS CUI [3])
Therapeutic radiology procedure | Radiofrequency ablation | Cryosurgery Percutaneous | Chemoembolization of hepatic artery Measurable Disease Site All
Item
prior radiation therapy, radiofrequency ablation, percutaneous cryotherapy or hepatic chemoembolization on all sites of measurable disease.
boolean
C1522449 (UMLS CUI [1])
C0850292 (UMLS CUI [2])
C0010408 (UMLS CUI [3,1])
C0522523 (UMLS CUI [3,2])
C2711393 (UMLS CUI [4,1])
C1513041 (UMLS CUI [4,2])
C1515974 (UMLS CUI [4,3])
C0444868 (UMLS CUI [4,4])
CNS metastases
Item
current or prior history of central nervous system metastases.
boolean
C0686377 (UMLS CUI [1])
Peripheral Neuropathy CTCAE Grades
Item
peripheral neuropathy ≥ grade 2 (ctcae v3.0) at registration.
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Arterial thrombosis | Venous Thrombosis
Item
history of arterial or venous thrombosis within 1 year prior to registration.
boolean
C0151942 (UMLS CUI [1])
C0042487 (UMLS CUI [2])
Bleeding tendency | Hemorrhage
Item
history of bleeding diathesis or bleeding within 14 days of registration.
boolean
C1458140 (UMLS CUI [1])
C0019080 (UMLS CUI [2])
Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure
Item
uncontrolled hypertension (systolic >145 mmhg; diastolic >85 mmhg).
boolean
C1868885 (UMLS CUI [1])
C0871470 (UMLS CUI [2])
C0428883 (UMLS CUI [3])
Heart Disease Clinical Significance
Item
clinically significant cardiac disease within 12 months of registration.
boolean
C0018799 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
HIV Seropositivity | Hepatitis C positive | Hepatitis B surface antigen positive
Item
known hiv positive, hepatitis c positive or hepatitis b surface antigen positive.
boolean
C0019699 (UMLS CUI [1])
C1112419 (UMLS CUI [2])
C0149709 (UMLS CUI [3])
Targeted Therapy VEGFR
Item
prior treatment with vegfr targeted therapies.
boolean
C2985566 (UMLS CUI [1,1])
C0148199 (UMLS CUI [1,2])
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial